Salbutamol treatment in a patient with hyperkalaemic periodic paralysis due to a mutation in the skeletal muscle sodium channel gene (SCN4A)

Journal of Neurology Neurosurgery and Psychiatry

Volumn 65, Issue 2, 1998, Pages 248-250

  Hanna, M G ^a   Stewart, J ^a   Schapira, A H V ^a   Wood, N W ^a   Morgan Hughes, J A ^a   Murray, N M F ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Hyperkalaemic periodic paralysis; Salbutamol; Sodium channel gene (SCN4A)

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; DIURETIC AGENT; METHIONINE; SALBUTAMOL; SODIUM CHANNEL; THREONINE;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CASE REPORT; CHROMOSOME 17Q; CLINICAL FEATURE; DNA SEQUENCE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; ELECTROPHYSIOLOGY; EXERCISE TEST; FEMALE; GENE MUTATION; HUMAN; PERIODIC PARALYSIS; POINT MUTATION; PRIORITY JOURNAL; PROVOCATION; SKELETAL MUSCLE;

EID: 0031873856     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.65.2.248     Document Type: Article

References (8)

1. Lehmann-Horn F, Engel AG, Ricker K, et al. The periodic paralyses and paramyotonia congenita. In: Engel AG, Franzini-Armstrong C, eds. Myology. 2nd ed. McGraw-Hill, New York, 1994:1303-402.
2. Ptacek LJ, George AL, Griggs RC, et al. Identification of a mutation in the gene causing hyperkalaemic periodic paralysis. Cell 1991;67:1021-7.
3. Subramony SH, Wee AS. Exercise and rest in hyperkalaemic periodic paralysis. Neurology 1986;36:173.
4. McManis PG, Lambert EH, Jasper RD. The exercise test in periodic paralysis. Muscle Nerve 1986;9:704-10.
5. Lehmann-Horn, Rudel R. Molecular pathophysiology of voltage-gated ion channels. Rev Physiol Biochem Pharmacol 1996;128:196-268.
6. Wang P, Clusen T. Treatment of hyperkalaemic periodic paralysis by inhalation of salbutamol. Lancet 1976;i:221.
7. Benheim PE, Reale EO, Berg BO. β-Adrenergic treatment of hyperkalaemic periodic paralysis. Neurology 1985;35: 746.
8. + transport in skeletal muscle. Physiol Rev 1986;66:542.